This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Graziadei, I W Articles by Vogel, W Search for Related Content PubMed PubMed Citation Articles by Graziadei, I W Articles by Vogel, W Social Bookmarking                   What's this?

Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis

Department of Gastroenterology and Hepatology, University of Innsbruck, Innsbruck, Austria, ivo.graziadei{at}uibk.ac.at

G E Obermoser

Department of Dermatology, University of Innsbruck, Innsbruck, Austria

N T Sepp

Department of Dermatology, University of Innsbruck, Innsbruck, Austria

K H Erhart

District Hospital, Bregenz, Austria

W Vogel

Department of Gastroenterology and Hepatology, University of Innsbruck, Innsbruck, Austria

Atorvastatin and other members of the statin family are widely used for the treatment of hypercholesterolaemia in order to reduce the risk of atherosclerosis and cardiovascular disease. Atorvastatin-induced adverse events are mostly mild and only a few cases of lupus-like syndrome or severe acute hepatitis have been documented. In this case report we describe a patient who developed an atorvastatin-induced severe autoimmune hepatitis. In addition, this patient presented with a concomitant systemic lupus-like syndrome which has been already described for statins but not in association with severe liver disease. Although the drug was immediately withdrawn the disease persisted and even deteriorated to a fulminant disease with evidence of acute hepatic failure. The patient failed to respond to conventional immunosuppression with corticosteroids and azathioprine. Only the introduction of intense immunosuppressive therapy, as used in solid organ transplantation, led to a complete and sustained recovery of the patient. Interestingly, the patient was HLA DR3- and HLA DR4-positive, which are well-known genetic factors associated with autoimmune diseases. This case is the first report of a drug-induced lupus-like syndrome concomitant with a severe autoimmune hepatitis in a genetically predisposed patient.

Key Words: atorvastatin • lupus-like syndrome • liver failure • autoimmune hepatitis

Lupus, Vol. 12, No. 5, 409-412 (2003)
DOI: 10.1191/0961203303lu313cr


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. A. Ferreira, T. P. Navarro, R. W. Telles, L. E. C. Andrade, and E. I. Sato Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial Rheumatology, October 1, 2007; 46(10): 1560 - 1565. [Abstract] [Full Text] [PDF]

				S Vasoo Drug-induced lupus: an update Lupus, November 1, 2006; 15(11): 757 - 761. [Abstract] [PDF]

				E. L. Krawitt Autoimmune Hepatitis N. Engl. J. Med., January 5, 2006; 354(1): 54 - 66. [Full Text] [PDF]

				B. Noel Statins and lupus erythematosus Rheumatology, March 1, 2004; 43(3): 397 - 398. [Full Text] [PDF]

				B. Noel Risks and Benefits of Statins in Lupus Erythematosus Arch Intern Med, January 12, 2004; 164(1): 107 - 108. [Full Text] [PDF]